Found: 7
Select item for more details and to access through your institution.
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 145, doi. 10.2165/11590330-000000000-00000
- By:
- Publication type:
- Article
Chronic Heart Failure.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 153, doi. 10.2165/11592090-000000000-00000
- By:
- Publication type:
- Article
Prognostic Utility of Serum Potassium in Chronic Digoxin Toxicity.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 173, doi. 10.2165/11590340-000000000-00000
- By:
- Publication type:
- Article
Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 179, doi. 10.2165/11592560-000000000-00000
- By:
- Publication type:
- Article
ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 189, doi. 10.2165/11589400-000000000-00000
- By:
- Publication type:
- Article
QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 199, doi. 10.2165/11591750-000000000-00000
- By:
- Publication type:
- Article
Neointimal Hyperplasia Inhibition Effect of Angiotensin II Type 1 Receptor Blockers in Patients after Coronary Stent Implantation.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 209, doi. 10.2165/11591780-000000000-00000
- By:
- Publication type:
- Article